Therefore, this study is aimed at exploring the expression of FNDC1, FNDC3A, FNDC3B, FNDC4, FNDC5, and GPR116 in nonaffected and affected mucosa samples of patients with IBD or CRC. This evidence concerns the gene ADGRF5 and inflammatory bowel disease.